• Je něco špatně v tomto záznamu ?

A118G polymorphism of OPRM1 gene is associated with schizophrenia

O. Serý, R. Prikryl, L. Castulík, F. St'astný,

. 2010 ; 41 (1) : 219-22. [pub] 20100129

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12025949
E-zdroje Online Plný text

NLK ProQuest Central od 1997-02-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 1997-02-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-02-01 do Před 1 rokem
Psychology Database (ProQuest) od 1997-02-01 do Před 1 rokem

Schizophrenia is ranked among multifactor diseases in whose pathogenesis, besides environmental factors, an interplay of functional polymorphisms of a larger number of candidate genes is involved. Neurodevelopmental abnormities are among the most accepted hypotheses in the etiology of schizophrenia. Recently, the role of oligodendrocytes in the development of the cortex has been cited repeatedly. During their various phases of differentiation oligodendrocytes present on their surfaces diverse receptors, among others the mu-opioid receptor (OPRM1). The study was focused on the relationship between the functional A118G polymorphism of the OPRM1 gene (rs1799971) and schizophrenia in groups of 130 male patients and 452 male controls. An association study revealed yet unpublished statistically significant difference of allelic and genotypic frequencies between the control and patient groups. According to our present knowledge, we assume that the OPRM1 gene polymorphism can influence the myelination of CNS neurons through regulations of expression of OPRM1 receptors on surfaces of oligodendrocytes. The neuronal myelination seems to be one of the important factors in the pathogenesis of schizophrenia.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12025949
003      
CZ-PrNML
005      
20230331114533.0
007      
ta
008      
120817s2010 xxu f 000 0#eng||
009      
AR
024    7_
$a 10.1007/s12031-010-9327-z $2 doi
035    __
$a (PubMed)20112002
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Serý, Omar $u Laboratory of Neurobiology and Molecular Psychiatry, Laboratory of Molecular Physiology, Department of Biochemistry, Faculty of Science, Masaryk University, Kotlárská 2, 611 37, Brno, Czech Republic. omarsery@sci.muni.cz
245    10
$a A118G polymorphism of OPRM1 gene is associated with schizophrenia / $c O. Serý, R. Prikryl, L. Castulík, F. St'astný,
520    9_
$a Schizophrenia is ranked among multifactor diseases in whose pathogenesis, besides environmental factors, an interplay of functional polymorphisms of a larger number of candidate genes is involved. Neurodevelopmental abnormities are among the most accepted hypotheses in the etiology of schizophrenia. Recently, the role of oligodendrocytes in the development of the cortex has been cited repeatedly. During their various phases of differentiation oligodendrocytes present on their surfaces diverse receptors, among others the mu-opioid receptor (OPRM1). The study was focused on the relationship between the functional A118G polymorphism of the OPRM1 gene (rs1799971) and schizophrenia in groups of 130 male patients and 452 male controls. An association study revealed yet unpublished statistically significant difference of allelic and genotypic frequencies between the control and patient groups. According to our present knowledge, we assume that the OPRM1 gene polymorphism can influence the myelination of CNS neurons through regulations of expression of OPRM1 receptors on surfaces of oligodendrocytes. The neuronal myelination seems to be one of the important factors in the pathogenesis of schizophrenia.
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a polymorfismus genetický $7 D011110
650    _2
$a receptory opiátové mu $x genetika $7 D017450
650    _2
$a schizofrenie $x genetika $x patofyziologie $7 D012559
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Prikryl, Radovan
700    1_
$a Castulík, Lukás
700    1_
$a St'astný, Frantisek
773    0_
$w MED00180364 $t Journal of molecular neuroscience $x 1559-1166 $g Roč. 41, č. 1 (2010), s. 219-22
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20112002 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120817 $b ABA008
991    __
$a 20230331114528 $b ABA008
999    __
$a ok $b bmc $g 947991 $s 783295
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 41 $c 1 $d 219-22 $e 20100129 $i 1559-1166 $m Journal of molecular neuroscience $n J Mol Neurosci $x MED00180364
LZP    __
$a Pubmed-20120817/10/03

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...